| The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation J Steffel, P Verhamme, TS Potpara, P Albaladejo, M Antz, L Desteghe, ... European heart journal 39 (16), 1330-1393, 2018 | 3121 | 2018 |
| Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ... The Lancet 391 (10117), 219-229, 2018 | 922 | 2018 |
| Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES T Vanassche, MN Lauw, JW Eikelboom, JS Healey, RG Hart, M Alings, ... European heart journal 36 (5), 281-288, 2015 | 384 | 2015 |
| Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant JD Douketis, AC Spyropoulos, J Duncan, M Carrier, G Le Gal, AJ Tafur, ... JAMA internal medicine 179 (11), 1469-1478, 2019 | 365 | 2019 |
| Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double … JP Piccini, V Caso, SJ Connolly, KAA Fox, J Oldgren, WS Jones, ... The lancet 399 (10333), 1383-1390, 2022 | 162 | 2022 |
| Embolic strokes of undetermined source: prevalence and patient features in the ESUS Global Registry KS Perera, T Vanassche, J Bosch, M Giruparajah, B Swaminathan, ... International journal of stroke 11 (5), 526-533, 2016 | 142 | 2016 |
| Adhesion of Staphylococcus aureus to the vessel wall under flow is mediated by von Willebrand factor–binding protein J Claes, T Vanassche, M Peetermans, L Liesenborghs, C Vandenbriele, ... Blood, The Journal of the American Society of Hematology 124 (10), 1669-1676, 2014 | 131 | 2014 |
| Staphylococcus aureus, master manipulator of the human hemostatic system L Liesenborghs, P Verhamme, T Vanassche Journal of Thrombosis and Haemostasis 16 (3), 441-454, 2018 | 108 | 2018 |
| Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonists N De Crem, K Peerlinck, T Vanassche, K Vanheule, B Debaveye, ... Thrombosis research 136 (4), 749-753, 2015 | 104 | 2015 |
| Venous thromboembolism in the elderly: efficacy and safety of non-VKA oral anticoagulants V Geldhof, C Vandenbriele, P Verhamme, T Vanassche Thrombosis Journal 12 (1), 21, 2014 | 103 | 2014 |
| Staphylococcus aureus endocarditis: distinct mechanisms of bacterial adhesion to damaged and inflamed heart valves L Liesenborghs, S Meyers, M Lox, M Criel, J Claes, M Peetermans, ... European heart journal 40 (39), 3248-3259, 2019 | 97 | 2019 |
| Venous thromboembolism in patients discharged after COVID-19 hospitalization MM Engelen, C Vandenbriele, T Balthazar, E Claeys, J Gunst, I Guler, ... Seminars in thrombosis and hemostasis 47 (04), 362-371, 2021 | 95 | 2021 |
| Global survey of the frequency of atrial fibrillation–associated stroke: Embolic Stroke of Undetermined Source Global Registry KS Perera, T Vanassche, J Bosch, B Swaminathan, H Mundl, ... Stroke 47 (9), 2197-2202, 2016 | 95 | 2016 |
| External reviewers. 2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation J Steffel, R Collins, M Antz, P Cornu, L Desteghe, KG Haeusler, J Oldgren, ... Europace 23 (10), 1612-1676, 2021 | 84 | 2021 |
| Coagulation: At the heart of infective endocarditis L Liesenborghs, S Meyers, T Vanassche, P Verhamme Journal of Thrombosis and Haemostasis 18 (5), 995-1008, 2020 | 84 | 2020 |
| Clumping factor A, von Willebrand factor‐binding protein and von Willebrand factor anchor Staphylococcus aureus to the vessel wall J Claes, L Liesenborghs, M Peetermans, TR Veloso, D Missiakas, ... Journal of Thrombosis and Haemostasis 15 (5), 1009-1019, 2017 | 81 | 2017 |
| Real‐world variability in dabigatran levels in patients with atrial fibrillation NC Chan, M Coppens, J Hirsh, JS Ginsberg, JI Weitz, T Vanassche, ... Journal of Thrombosis and Haemostasis 13 (3), 353-359, 2015 | 78 | 2015 |
| Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulence T Vanassche, J Verhaegen, WE Peetermans, J Van Ryn, A Cheng, ... Journal of Thrombosis and Haemostasis 9 (12), 2436-2446, 2011 | 75 | 2011 |
| Development of a risk prediction score for occult cancer in patients with VTE L Jara-Palomares, R Otero, D Jimenez, M Carrier, I Tzoran, B Brenner, ... Chest 151 (3), 564-571, 2017 | 73 | 2017 |
| Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials T Vanassche, J Hirsh, JW Eikelboom, JS Ginsberg Thrombosis and haemostasis 112 (11), 918-923, 2014 | 73 | 2014 |
